Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells.

Citation data:

PloS one, ISSN: 1932-6203, Vol: 7, Issue: 10, Page: e44915

Publication Year:
2012
Usage 5927
Full Text Views 5490
Downloads 314
Abstract Views 82
Views 41
Captures 67
Readers 65
Exports-Saves 2
Citations 38
Citation Indexes 38
Repository URL:
https://escholarship.umassmed.edu/oapubs/2372; https://works.bepress.com/gyongyi_szabo/154
PMID:
23071503
DOI:
10.1371/journal.pone.0044915; 10.1371/journal.pone.0044915.g001; 10.1371/journal.pone.0044915.g003; 10.1371/journal.pone.0044915.t001; 10.1371/journal.pone.0044915.t002; 10.1371/journal.pone.0044915.g004; 10.1371/journal.pone.0044915.g002
PMCID:
PMC3468613; 3468613
Author(s):
Angela Dolganiuc; Karen Kodys; Christopher Marshall; Banishree Saha; Shuye Zhang; Shashi Bala; Gyongyi Szabo; Fu-Sheng Wang
Publisher(s):
Public Library of Science (PLoS); Figshare
Tags:
Agricultural and Biological Sciences; Biochemistry, Genetics and Molecular Biology; Medicine; Chemistry; Immunology; iii; il-28; are; hcv; induce; myeloid; dendritic; cell-mediated; cells; treatment-induced; inhibitory; dcs; phenotype; il-10; Hepacivirus; Hepatitis C, Chronic; Interferon-alpha; Digestive System Diseases; Immunology and Infectious Disease; Virus Diseases; correlates; levels; proliferation; influences; analyses; generated; characteristics
article media
article description
Hepatitis C virus (HCV) is difficult to eradicate and type III interferons (IFN-λ, composed of IL-28A, IL-28B and IL-29) are novel therapeutic candidates. We hypothesized that IFN-λ have immunomodulatory effects in HCV- infected individuals.